MABVAX THERAPEUTICS HOLDINGS, INC. Proceeds from Notes Payable
MABVAX THERAPEUTICS HOLDINGS, INC. reported Proceeds from Notes Payable of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2017-11-07
- MABVAX THERAPEUTICS HOLDINGS, INC. proceeds from notes payable for the quarter ending 2017-09-30 was $0.00.
- MABVAX THERAPEUTICS HOLDINGS, INC. proceeds from notes payable for the quarter ending 2017-06-30 was $0.00.
- MABVAX THERAPEUTICS HOLDINGS, INC. proceeds from notes payable for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- MABVAX THERAPEUTICS HOLDINGS, INC. proceeds from notes payable for the quarter ending 2016-09-30 was $0.00.
- MABVAX THERAPEUTICS HOLDINGS, INC. proceeds from notes payable for fiscal 2008 was $8.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-22 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $4.61M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $4.61M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $4.61M 10-Q · filed 2017-05-22 | |||
| 2008-12-31 | $8.00M 10-K · filed 2013-03-15 |